DMAA
Drugs Made In America Acquisition Corp.
$10.66
+0.00 (+0.00%)
At close · Jul 7
Market Cap
$258.55M
Shares
24,276,913
Income-statement, balance-sheet and cash-flow figures extracted from the company's SEC filings — 10-K annual and 10-Q quarterly reports — and standardised for comparison across periods.
Net Income
$5.94M
+2222.8%
FY2025
Diluted EPS
-$0.03
FY2024
Operating Cash Flow
-$539.19K
-213%
FY2025
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2025 | FY2024 |
|---|---|---|---|
| $2.63M | $2.82M | $279.85K | |
| -$2.63M | -$2.82M | — | |
| $9.28M | $8.76M | — | |
| $9.28M | $8.76M | — | |
| $6.66M | $5.94M | -$279.85K | |
| USD/shares | — | — | -$0.03 |
| USD/shares | — | — | -$0.03 |
| shares | — | — | 8.57M |
| shares | — | — | 8.57M |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest.
Key facts
CIK
2028614
CUSIP
G2847J104
13F (30d)
1 filings
1 filers